SET-C versus fluoxetine in the treatment of childhood social phobia

Authors

    Authors

    D. C. Beidel; S. M. Turner; F. R. Sallee; R. T. Ammerman; L. A. Crosby;S. Pathak

    Comments

    Authors: contact us about adding a copy of your work at STARS@ucf.edu

    Abbreviated Journal Title

    J. Am. Acad. Child Adolesc. Psychiatr.

    Keywords

    fluoxetine; Social Effectiveness Therapy for Children; cognitive-behavioral therapy; social phobia; pharmacological treatment; RANDOMIZED CLINICAL-TRIAL; COGNITIVE-BEHAVIORAL INTERVENTION; TREATING; ANXIETY DISORDERS; GROUP-THERAPY; ADOLESCENTS; CHILDREN; SKILLS; Psychology, Developmental; Pediatrics; Psychiatry

    Abstract

    Objective: To determine the efficacy of fluoxetine, pill placebo, and Social Effectiveness Therapy for Children (SET-C) for children and adolescents with social phobia. Method: Youths ages 7 to 17 were randomly assigned to one of the treatment conditions. Outcome was evaluated using self-reports, parent ratings, independent evaluator ratings, and behavioral assessment. Results: Both fluoxetine and SET-C were more efficacious than placebo in reducing social distress and behavioral avoidance and increasing general functioning. SET-C was superior to fluoxetine on each of these measures and was the only treatment superior to placebo in terms of improving social skills, decreasing anxiety in specific social interactions, and enhancing ratings of social competence. Furthermore, whereas fluoxetine appears to exert maximum effect by 8 weeks, SET-C provides continued improvement through week 12. Conclusions: Both fluoxetine and SET-C are efficacious for social phobia, although SET-C appears to provide added benefit by enhancing social skills.

    Journal Title

    Journal of the American Academy of Child and Adolescent Psychiatry

    Volume

    46

    Issue/Number

    12

    Publication Date

    1-1-2007

    Document Type

    Article

    Language

    English

    First Page

    1622

    Last Page

    1632

    WOS Identifier

    WOS:000251141800011

    ISSN

    0890-8567

    Share

    COinS